BOSTON, July 19, 2021 (World NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a medical stage biopharmaceutical corporation focused on developing medicine that meaningfully boost the
Tag: Therapeutics
FREQUENCY THERAPEUTICS Trader Inform: Buyers With Sizeable Losses Have Prospect to Direct the Frequency Therapeutics, Inc. Course Motion Lawsuit
SAN DIEGO, July 12, 2021–(Business WIRE)–Robbins Geller Rudman & Dowd LLP announces that a class action lawsuit has been submitted in the District of Massachusetts
Melinta Therapeutics Announces Appointment of Susan Blum as Main Fiscal Officer
MORRISTOWN, N.J.–(Company WIRE)–Melinta Therapeutics, LLC (“Melinta”), a industrial-stage organization giving progressive therapies for acute and lifestyle-threatening sicknesses, announces the appointment of Susan Blum as Main
Melinta Therapeutics Announces Appointment of Susan Blum as Main Financial Officer
MORRISTOWN, N.J., June 29, 2021–(Enterprise WIRE)–Melinta Therapeutics, LLC (“Melinta”), a business-phase business delivering ground breaking therapies for acute and existence-threatening ailments, announces the appointment of
Vera Therapeutics Reports First Quarter 2021 Financial
Completed an initial public offering with net proceeds, including the exercise of the underwriters’ option in full, of approximately $48.4 million in May 2021 –
C4 Therapeutics Appoints Lauren White as Chief Economic Officer
WATERTOWN, Mass., May possibly 20, 2021 (Globe NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical corporation groundbreaking a new class of little-molecule medications
Global Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight Report 2021-2026 Featuring Acopedia, Takeda Pharma, TC Biopharma and Adapate Therapeutics
Dublin, May 20, 2021 (GLOBE NEWSWIRE) — The “Global Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight 2026” report has been added
Aileron Therapeutics to Host KOL Virtual Investor Celebration Speaking about Possibility for New Paradigm to Protect Cancer People from Chemotherapy-Induced Toxicities
— Hearth chat, moderated by Soumit Roy, Ph.D. of JonesTrading, will be held on Wednesday, May 26, 2021 at 11:00 am ET — — Showcased
Denali Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
SOUTH SAN FRANCISCO, Calif., May 03, 2021 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates
Oncternal Therapeutics to Report Very first Quarter 2021 Fiscal Success and Give Enterprise Update
SAN DIEGO, April 29, 2021 (World NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a medical-phase biopharmaceutical business centered on the growth of novel oncology therapies,